Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2416 participants.
Also called NCT03090113
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 2,416 participants
- Sponsor
- Registry
-
NCT03090113
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03090113. Randomized; quadruple masking; primary purpose prevention. Start 2017-05-12 (actual); primary completion 2019-03-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism
- Acronym
- SPACE
- Condition
- Embolic Stroke
- Intervention (Drug)
- Shuxuetong Injection
- Intervention (Drug)
- Placebo Injection
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct03090113- Content hash
7c363040735b31e8aa307ae778674e44b3a6fb4bcfcb70c8c1caced2398412fc